Citius Pharmaceuticals Inc.
13F holders, Q3 2024 (September 30)58holders −14
7new positions
21sold out
1famous investor
$0.50avg. 13F price*
At the end of Q3 2024, 58 institutions reported holding Citius Pharmaceuticals Inc. in their 13F filings, down 14 from Q2 2024. 7 opened new positions and 21 sold out. The largest holders were Armistice Capital, LLC ($3.6M), Vanguard Group Inc. ($3.2M) and Geode Capital Management, LLC ($941K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Citius Pharmaceuticals Inc.
- CUSIP
- 17322U207
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $455K |
| Exits | 21 | $734K |
All 13F filers, Q2 2024 → Q3 2024: 1,440,046 shares bought and 8,460,398 shares sold, net −7,020,352 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 58 holders
| Armistice Capital, LLC | 0.10% | Reduce -28.4% | 7,276,000 | $3.6M |
| Vanguard Group Inc. | 0.00% | Add +1.8% | 6,440,828 | $3.2M |
| Geode Capital Management, LLC | 0.00% | Add +14.1% | 1,878,953 | $941K |
| BlackRock, Inc. | 0.00% | — | 1,805,726 | $904K |
| Millennium Management | 0.00% | Reduce -43.5% | 1,158,508 | $580K |
| Osaic Holdings, Inc. | 0.00% | Reduce -0.1% | 931,833 | $466K |
| Squarepoint Ops LLC | 0.00% | New | 659,379 | $330K |
| State Street Corp. | 0.00% | No change | 581,797 | $291K |
| Northern Trust Corp. | 0.00% | Reduce -69.7% | 319,356 | $160K |
| Chelsea Counsel Co. | 0.07% | Add +9.8% | 281,300 | $141K |
| HighTower Advisors, LLC | 0.00% | No change | 215,020 | $107K |
| Wealth Advisory Solutions, LLC | 0.03% | Add +33.1% | 201,000 | $101K |
| Arkadios Wealth Advisors | 0.01% | Add +33.3% | 200,000 | $100K |
| Susquehanna International Group, LLP | 0.00% | Reduce -74.2% | 165,063 | $83K |
| Inspire Advisors, LLC | 0.01% | Reduce -0.2% | 157,938 | $79K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | Reduce -50.2% | 100,535 | $50K |
| Virtu Financial LLC | 0.00% | New | 100,406 | $50K |
| Miller Investment Management, LP | 0.01% | Add +99.3% | 99,640 | $50K |
| Jane Street Group, LLC | 0.00% | Reduce -75.6% | 93,446 | $47K |
| XTX Topco Ltd | 0.00% | New | 93,259 | $47K |
| Kestra Advisory Services, LLC | 0.00% | Reduce -1.1% | 92,519 | $46K |
| Blair William & Co. | 0.00% | Reduce -5.2% | 91,200 | $46K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 76,073 | $38K |
| Horst & Graben Wealth Management LLC | 0.01% | No change | 75,722 | $38K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -68.8% | 72,088 | $36K |
| Private Advisor Group, LLC | 0.00% | Reduce -0.1% | 40,000 | $20K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -96.8% | 37,940 | $19K |
| HRT Financial LP | 0.00% | Reduce -62.9% | 37,182 | $18K |
| IFP Advisors, Inc | 0.00% | New | 33,333 | $17K |
| HUB Investment Partners, LLC | 0.00% | No change | 30,000 | $15K |
| Bank of America Corp. | 0.00% | Reduce -81.8% | 28,930 | $14K |
| Catalyst Funds Management Pty Ltd | 0.00% | No change | 27,200 | $14K |
| Victory Capital Management Inc. | 0.00% | Reduce -1.7% | 21,372 | $11K |
| Group One Trading LLC | 0.00% | Reduce -13.4% | 20,650 | $10K |
| Financial Engines Advisors L.L.C. | 0.00% | New | 20,000 | $10K |
| Keynote Financial Services LLC | 0.01% | No change | 17,500 | $9K |
| Citigroup Inc. | 0.00% | Reduce -11.4% | 15,940 | $8K |
| Bank of New York Mellon Corp | 0.00% | Add +0.0% | 14,633 | $7K |
| LPL Financial LLC | 0.00% | Reduce -81.3% | 11,485 | $6K |
| Csenge Advisory Group | 0.00% | No change | 15,000 | $6K |
| Ethos Financial Group, LLC | 0.00% | No change | 10,000 | $5K |
| Fairscale Capital, LLC | 0.00% | No change | 9,155 | $5K |
| Simplex Trading, LLC | 0.00% | Reduce -19.9% | 8,543 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -90.7% | 4,044 | $2K |
| Princeton Global Asset Management LLC | 0.00% | No change | 4,000 | $2K |
| Blue Trust, Inc. | 0.00% | No change | 3,000 | $2K |
| Sanctuary Advisors, LLC | 0.00% | New | 12,500 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 3,041 | $2K |
| BNP Paribas Financial Markets | 0.00% | No change | 2,984 | $1K |
| Quent Capital, LLC | 0.00% | No change | 2,752 | $1K |
| Morgan Stanley | 0.00% | Reduce -84.6% | 1,500 | $751 |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -98.9% | 1,301 | $651 |
| UBS Group AG | 0.00% | Reduce -99.0% | 605 | $303 |
| Allworth Financial LP | 0.00% | New | 300 | $151 |
| Aspire Private Capital, LLC | 0.00% | No change | 300 | $150 |
| WR Wealth Planners, LLC | 0.00% | No change | 100 | $50 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 16 | $8 |
| Barclays PLC | 0.00% | Reduce -100.0% | 1 | $1 |
"% of holder's portfolio" is CITIUS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Citius Pharmaceuticals Inc. the manager owns.